Skip to main content
. 2024 Jul 19;15:1445170. doi: 10.3389/fphar.2024.1445170

FIGURE 8.

FIGURE 8

Role of RAB42 knock-down in decreasing the cellular malignancy of LIHC. (A,B) Determining the knockdown efficiency of RAB42 in MHCC-97H and HepG2 cells by Western blotting. (C) The effect of RAB42 knockdown on cellular survival determined by CCK-8 assays. (D–F) The effect of RAB42 knockdown on cellular migratory potential determined by wound healing assays. Representative images are shown (D,E). (G,H) The effect of RAB42 knockdown on the cellular invasion potential determined by transwell assays. Representative images are shown (G). ns, not significant; *, p < 0.05; ***, p < 0.001; n = 3.